-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – VTP-400 in Herpes Zoster (Shingles)
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. VTP-400 in Herpes Zoster (Shingles) Drug Details: VTP-400 is under development for the prevention of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – SAR-442501 in Achondroplasia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - SAR-442501 in Achondroplasia report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. SAR-442501 in Achondroplasia Drug Details: SAR-442501 is under development for the treatment of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Influenza (Quadrivalent) Vaccine in Influenzavirus B Infections
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Influenza (Quadrivalent) Vaccine in Influenzavirus B Infections report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Influenza (Quadrivalent) Vaccine in Influenzavirus B Infections Drug Details:Vaccine is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – BI-1819479 in Idiopathic Pulmonary Fibrosis
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.BI-1819479 in Idiopathic Pulmonary Fibrosis Drug Details:BI-1819479 is under development for the treatment of unspecified indication,...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – VTP-300 in Hepatitis B
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.VTP-300 in Hepatitis BDrug Details:VTP-300 is under development for the treatment of hepatitis B. It is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – VTP-200 in Cervical Cancer
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.VTP-200 in Cervical CancerDrug Details:VTP-200 is under development for the treatment of HPV associated cervical cancer...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – VTP-200 in Cervical Intraepithelial Neoplasia (CIN)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.VTP-200 in Cervical Intraepithelial Neoplasia (CIN)Drug Details:VTP-200 is under development for the treatment of HPV associated...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – VTP-200 in Human Papillomavirus (HPV) Associated Cancer
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.VTP-200 in Human Papillomavirus (HPV) Associated CancerDrug Details:VTP-200 is under development for the treatment of HPV...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Divarasib in Pancreatic Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Divarasib in Pancreatic Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Divarasib in Pancreatic CancerDrug Details:Divarasib (GDC-6036 (RG6330)) is under development for the treatment...